Cover ImageSALE
市場調查報告書

POC血糖監測設備的全球市場:2018年∼2022年

Global POC Blood Glucose Monitoring Devices Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 556910
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
POC血糖監測設備的全球市場:2018年∼2022年 Global POC Blood Glucose Monitoring Devices Market 2018-2022
出版日期: 2018年02月09日 內容資訊: 英文 130 Pages
簡介

關於POC血糖監測設備

POC血糖監測設備是便攜式的近患者設備,可以立即檢測患者的血糖值,並在需要時提供快速治療方案。這些設備由最少的操作員交互作用,並且具有非侵入性,具有高效的數據管理和連接工具。

Technavio的分析師預測,全球POC血糖監測系統市場將以從2018年到2022年之間成長,達到2億3,640萬美元。

本報告提供全球POC血糖監測系統市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模及預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第7章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:各產品
  • 消耗品
  • 器具
  • 市場機會:各產品

第8章 客戶形勢

第9章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 醫院、診療所
  • 臨床診斷實驗室
  • 居家醫療

第10章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 非侵入性產品的病例轉移
  • 線上商品銷售的增加
  • 產品的商品搭售

第14章 業者情勢

  • 概要
  • 創造性破壞
  • 競爭情形

第15章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • 其他有力的供應商
  • 簡稱一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR21495

About POC Blood Glucose Monitoring Devices

POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools.

Technavio's analysts forecast the global POC blood glucose monitoring devices market to grow at a USD 2,036.4 million during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the POC blood glucose monitoring devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global POC Blood Glucose Monitoring Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson

Market driver

  • Public and private initiatives to reduce diabetic cases
  • For a full, detailed list, view our report

Market challenge

  • High cost associated with diabetes management
  • For a full, detailed list, view our report

Market trend

  • Paradigm shift towards non-invasive products
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Consumables
  • Instruments
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Home care settings

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • POC blood glucose monitoring devices market in Americas
  • POC blood glucose monitoring devices market in EMEA
  • POC blood glucose monitoring devices market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Paradigm shift towards non-invasive products
  • Increase in online product sales
  • Product bundling

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Other prominent vendors
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global IVD market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global POC blood glucose monitoring devices by Product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Consumables - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Product 1 - Year over year growth 2018-2022 (%)
  • Exhibit 22: Product 2 - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Product 2 - Year over year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global POC blood glucose monitoring devices market by end-user - Market share 2027 (%)
  • Exhibit 27: Global POC blood glucose monitoring devices - Market share by geography 2017-2022 (%)
  • Exhibit 28: Regional comparison
  • Exhibit 29: POC blood glucose monitoring devices market in the Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 30: POC blood glucose monitoring devices market in the Americas - Year over year growth 2018-2022 (%)
  • Exhibit 31: Top 3 countries in Americas
  • Exhibit 32: POC blood glucose monitoring devices market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: POC blood glucose monitoring devices market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 34: Top 3 countries in EMEA
  • Exhibit 35: POC blood glucose monitoring devices market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: POC blood glucose monitoring devices market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 37: Top 3 countries in APAC
  • Exhibit 38: Global POC blood glucose monitoring devices market opportunity
  • Exhibit 39: Various programs to reduce cost burden for diabetics
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Competitive structure analysis of global POC blood glucose monitoring devices market 2016
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Market positioning of vendors
  • Exhibit 51: Abbott overview
  • Exhibit 52: Abbott - Business segments
  • Exhibit 53: Abbott - Organizational developments
  • Exhibit 54: Abbott - Geographic focus
  • Exhibit 55: Abbott- Segment focus
  • Exhibit 56: Abbott - Key offerings
  • Exhibit 57: Abbott - Key customers
  • Exhibit 58: ARKRAY overview
  • Exhibit 59: ARKRAY - Business segments
  • Exhibit 60: ARKRAY - Organizational developments
  • Exhibit 61: ARKRAY- Geographic focus
  • Exhibit 62: ARKRAY- Segment focus
  • Exhibit 63: ARKRAY - Key offerings
  • Exhibit 64: ARKRAY- Key customers
  • Exhibit 65: Ascensia Diabetes Care overview
  • Exhibit 66: Ascensia Diabetes Care- Business segments
  • Exhibit 67: Ascensia Diabetes Care - Organizational developments
  • Exhibit 68: Ascensia Diabetes Care - Geographic focus
  • Exhibit 69: Ascensia Diabetes Care - Segment focus
  • Exhibit 70: Ascensia Diabetes Care - Key offerings
  • Exhibit 71: Ascensia Diabetes Care - Key customers
  • Exhibit 72: Danaher overview
  • Exhibit 73: Danaher - Business segments
  • Exhibit 74: Danaher - Organizational developments
  • Exhibit 75: Danaher - Geographic focus
  • Exhibit 76: Danaher - Segment focus
  • Exhibit 77: Danaher- Key offerings
  • Exhibit 78: Danaher- Key customers
  • Exhibit 79: F. Hoffmann-La Roche overview
  • Exhibit 80: F. Hoffmann-La Roche - Business segments
  • Exhibit 81: F. Hoffmann-La Roche- Organizational developments
  • Exhibit 82: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 83: F. Hoffmann-La Roche - Segment focus
  • Exhibit 84: F. Hoffmann-La Roche - Key offerings
  • Exhibit 85: F. Hoffmann-La Roche - Key customers
  • Exhibit 86: Vendor overview
  • Exhibit 87: Vendor 1 - Business segments
  • Exhibit 88: Vendor 1 - Organizational developments
  • Exhibit 89: Vendor 1 - Geographic focus
  • Exhibit 90: Vendor 1 - Segment focus
  • Exhibit 91: Vendor 1 - Key offerings
  • Exhibit 92: Vendor 1 - Key customers
Back to Top